| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |